| A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation A Dheeraj, C Agarwal, IR Schlaepfer, D Raben, R Singh, R Agarwal, ... Hypoxia, 23-33, 2018 | 38 | 2018 |
| Silibinin treatment inhibits the growth of Hedgehog inhibitor‐resistant basal cell carcinoma cells via targeting EGFR‐MAPK‐Akt and Hedgehog signaling A Dheeraj, CM Rigby, CL O'Bryant, C Agarwal, RP Singh, G Deep, ... Photochemistry and photobiology 93 (4), 999-1007, 2017 | 24 | 2017 |
| Synthesis and in vitro study of artemisinin/synthetic peroxide‐based hybrid compounds against SARS‐CoV‐2 and cancer L Herrmann, IA Yaremenko, A Çapcı, J Struwe, D Tailor, A Dheeraj, ... ChemMedChem 17 (9), e202200005, 2022 | 17 | 2022 |
| Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer D Tailor, CC Going, A Resendez, V Kumar, DK Nambiar, Y Li, A Dheeraj, ... British Journal of Cancer 124 (3), 604-615, 2021 | 16 | 2021 |
| Anticancer effects and associated molecular changes of Carica papaya against prostate cancer SP Singh, SV Mathan, A Dheeraj, D Tailor, RP Singh, A Acharya Cancer Research 79 (13_Supplement), 3004-3004, 2019 | 10 | 2019 |
| Anticancer Attributes of silibinin: chemo-and radiosensitization of cancer A Dheeraj, D Tailor, SP Singh, RP Singh Role of nutraceuticals in cancer chemosensitization, 199-220, 2018 | 9 | 2018 |
| Reengineering ponatinib to minimize cardiovascular toxicity AP Hnatiuk, AAN Bruyneel, D Tailor, M Pandrala, A Dheeraj, W Li, ... Cancer research 82 (15), 2777-2791, 2022 | 7 | 2022 |
| A novel 4′‐brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non‐small‐cell lung cancer without any adverse … A Sabarwal, JC van Rooyen, J Caburet, M Avgenikos, A Dheeraj, M Ali, ... The FASEB Journal 36 (12), e22654, 2022 | 6 | 2022 |
| Decursin inhibits EGFR‐ERK1/2 signaling axis in advanced human prostate carcinoma cells TA Bhat, A Dheeraj, DK Nambiar, SP Singh, DS Yim, RP Singh The Prostate 83 (6), 534-546, 2023 | 1 | 2023 |
| Inhibition of triple negative breast cancer metastasis via Enolase-1 modulation D Tailor, A Dheeraj, FJ Garcia-Marques, M Pandrala, A Bermudez, ... Cancer Research 82 (12_Supplement), 1799-1799, 2022 | 1 | 2022 |
| Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors D Tailor, FJ Garcia-Marques, A Bermudez, W Li, A Dheeraj, SJ Pitteri, ... Cancer Research 84 (6_Supplement), 5935-5935, 2024 | | 2024 |
| YB-1 inhibition as an effective approach for the treatment of osteosarcoma K Stefan, A Dheeraj, D Tailor, LE Davis, SV Malhotra Cancer Research 84 (6_Supplement), 5926-5926, 2024 | | 2024 |
| Targeting metabolic pathway in triple negative breast cancer with a small molecule inhibitor A Dheeraj, FJ Marques, D Tailor, A Bermudez, B Grau, S Pitteri, ... Cancer Research 84 (6_Supplement), 7151-7151, 2024 | | 2024 |
| Y box binding protein 1 inhibitors SV Malhotra, D Tailor, A Dheeraj US Patent App. 18/255,827, 2024 | | 2024 |
| 4'-substituted analogues of fisetin and their use in the treatment of cancer CH Kaschula, RP Singh, A Dheeraj, A Sabarwal US Patent App. 18/039,397, 2024 | | 2024 |
| Synthesis of potent antileukemic quinazoline-thiohydantoin fused heterocycles enabled by metal-free domino reaction L Kersting, C Zippel, L Herrmann, EJ Seo, MEM Saeed, A Gaube, D Tailor, ... | | 2023 |
| A small molecule CET019 inhibits progression of triple negative breast cancer A Dheeraj, D Tailor, FJ Marques, B Grau, A Bermudez, S Pitteri, ... Cancer Research 83 (7_Supplement), 511-511, 2023 | | 2023 |
| The role of Mycobacterium w as a novel treatment for osteosarcoma K Stefan, A Dheeraj, D Tailor, S Kumar, W Li, R Modi, M Joshipura, ... Cancer Research 83 (7_Supplement), 554-554, 2023 | | 2023 |
| Desmocollin-3 and tumor immune microenvironment: Bioinformatics evaluation A Dheeraj, BM Khamar, CP Shukla, NK Jain, RI Modi Cancer Research 83 (7_Supplement), 881-881, 2023 | | 2023 |
| High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay S Kumar, D Tailor, A Dheeraj, W Li, JM Lee, K Stefan, D Nelson, ... Cancer Research 83 (7_Supplement), 3473-3473, 2023 | | 2023 |
